Back

Increased plasma ACE2 activity is a marker of subclinical LV systolic dysfunction in patients with aortic stenosis.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Impact of new parameters on aortic stenosis outcomes Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Jay Ramchand

Cleveland Clinic Foundation, Cleveland (United States of America)

11 More presentations in this session

Presentation thumbnail
The effect of age on the prevalence of aortic stenosis in a large retrospective echocardiographic study
Doctor S. Tyebally (London, GB)
Abstract
Presentation thumbnail
Prevalence and lifetime risk factors for aortic stenosis in a general population of middle aged men in Sweden with 21 years follow up.
Associate Professor E. Thunstrom (Gothenburg, SE)
Abstract
Presentation thumbnail
Impact of baseline left-ventricular ejection fraction on 30-day and 1-year outcome after transfemoral aortic valve implantation: Interaction with mean gradient across the aortic valve
Doctor K. El Chilali (Recklinghausen, DE)
Abstract
Presentation thumbnail
Global radiological exposure of TAVI: an unresolved issue with potential drawbacks in low and intermediate risk patients
Doctor L. Biasco (Cirie, IT)
Abstract
Presentation thumbnail
Impact of myocardial fibrosis on 10-year-outcome in patients undergoing aortic valve replacement
Doctor S. Herrmann (Bad Mergentheim, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Impact of new parameters on aortic stenosis outcomes

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources